 




<CFRNO>21 CFR Parts 510, 520, and 524 </CFRNO>



<DOCTITLE>Animal Drugs, Feeds, and Related Products; Change of Sponsor</DOCTITLE>


<AGENCY>
AGENCY:

 Food and Drug Administration, HHS.


</AGENCY>
<ACTION>
ACTION:

 Final rule.




</ACTION>
<SUMMARY>
SUMMARY:

 The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for five
new animal drug applications (NADA's) from Purina Mills, Inc., to PM Resources, Inc.

 
</SUMMARY>
<DATE>
EFFECTIVE DATE:

 June 3, 1994.


</DATE>
<FURTHER>
FOR FURTHER INFORMATION CONTACT:

 Benjamin A. Puyot, Center for Veterinary Medicine (HFV130), Food and Drug Administration, 7500 Standish
Pl., Rockville, MD 20855, 3015941646.


</FURTHER>
<SUPPLEM>
SUPPLEMENTARY INFORMATION:

 Purina Mills, Inc., P.O. Box 66812, St. Louis, MO 631666812, has informed FDA that it has transferred ownership
of, and all rights and interests in, the following approved NADA's to PM Resources, Inc., 13001 St. Charles Rock Rd.,
Bridgeton, MO 63044:


<TABLE>



1NADA number

1Ingredient 

1Trade name 


007076 

Sulfaquinoxaline Sodium

Sulfa-Nox Liquid.
008244

Sulfaquinoxaline Sodium

Sulfa-Nox Concentrate.
010886

Piperazine Phosphate Monohydrate

Purina Liquid Wormer.
043215

Famphur

Purina Grub-Kill.
092150

Pyrantel Tartrate

Purina Horse  Colt Wormer. 

</TABLE>



Accordingly, the agency is amending the regulations in 21 CFR Parts 510.600(c)(1) and (c)(2), 520.1806(b), 520.2045(b)(2),
520.2325a(c)(2), and 524.900(c) to reflect the change of sponsor. 


List of Subjects 


21 CFR Part 510


Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements.


21 CFR Parts 520 and 524


Animal drugs.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food
and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, and 524 are amended as follows:


PART 510_NEW ANIMAL DRUGS


1. The authority citation for 21 CFR part 510 continues to read as follows:





Authority:

 Secs. 201, 301, 501, 502, 503, 512, 701, 721 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351, 352,
353, 360b, 371, 379e).


2. Section 510.600 is amended in the table in paragraph (c)(1) by alphabetically adding a new entry for ``PM Resources,
Inc.,'' and in the table in paragraph (c)(2) by numerically adding a new entry for ``060594'' to read as follows:


 510.600 

Names, addresses, and drug labeler codes of sponsors of approved applications.


* * * * *


(c) ***
(1) ***


<TABLE>



1Firm name and address

1Drug labeler code 


*****


PM Resources, Inc.,
13001 St. Charles Rock Rd., 
Bridgeton, MO 63044

060594 


*****


</TABLE>


(2) ***



<TABLE>



1Drug labeler code

1Firm name and address


*****


060594

PM Resources, Inc.,
13001 St. Charles Rock Rd., 
Bridgeton, MO 63044



</TABLE>


PART 520_ORAL DOSAGE FORM NEW ANIMAL DRUGS


3. The authority citation for 21 CFR part 520 continues to read as follows:





Authority:

 Sec. 512 of the Federal, Food, Drug, and Cosmetic Act (21 U.S.C. 360b).


520.1806 

[Amended]


4. Section 520.1806 

Piperazine monohydrochloride liquid

 is amended in paragraph (b) by adding ``and 060594'' after ``017135''.


520.2045 

[Amended]


5. Section 520.2045 

Pyrantel tartrate powder; pyrantel tartrate pellets

 is amended in paragraph (b)(2) by removing ``017800'' and adding in its place ``060594''.


520.2325a 

[Amended]


6. Section 520.2325a 

Sulfaquinoxaline drinking water

 is amended in paragraph (c)(2) by removing ``017800'' and adding in its place ``060594''.


PART 524_OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS 


7. The authority citation for 21 CFR part 524 continues to read as follows:





Authority:

 Sec. 512 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b).


524.900 

[Amended]


8. Section 524.900 

Famphur

 is amended in paragraph (c) by removing ``017800'' and adding in its place ``060594''.




Dated: May 26, 1994.

</SUPPLEM>
<SIGNER>
Robert C. Livingston, 

</SIGNER>
<SIGNJOB>
Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

</SIGNJOB>
<FRFILING>
[FR Doc. 9413588 Filed 6294; 8:45 am]

</FRFILING>
<BILLING>
BILLING CODE 416001F
</BILLING>

